Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression

Abstract Objectives GPC3 has been recognized as a promising target for immunotherapy in hepatocellular carcinoma (HCC). However, the GPC3-targeted immunotherapies have shown limited therapeutic efficacy. The use of anti-PD-1/PD-L1 monoclonal antibodies in HCC treatment is considerably constrained. F...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingzhen Zhou, Ziyan Zhou, Lina Hu, Sidong Chen, Fanyan Meng, Jun Chen, Jie Shen
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-025-06106-0
Tags: Add Tag
No Tags, Be the first to tag this record!